Crossmark

Chromosome-wide gene dosage rebalance may benefit tumor progression

Crossref DOI link: https://doi.org/10.1007/s00438-018-1429-2

Published Online: 2018-03-15

Published Print: 2018-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhang, Honglei

Yang, Xing

Feng, Xu

Xu, Haibo

Yang, Qin

Zou, Li

Yan, Mei

Liu, Dequan

Su, Xiaosan

Jiao, Baowei
Funding

Funding for this research was provided by:

the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB13030400)

Applied Basic Research Foundation of Yunnan Province (No.2016FB038)

National Natural Science Foundation of China (No.31371502)

Open Project from state Key Laboratory of Genetic Resources and Evolution (No. GREKF15-11)

Open Project from State Key Laboratory of Genetic Resources and Evolution (No.GREKF14-05)
License Information

Text and Data Mining valid from 2018-03-15
More Information

Article History

Received: 29 August 2017

Accepted: 9 March 2018

First Online: 15 March 2018

Compliance with ethical standards

:

: The author(s) declare that he has no conflict of interest.

: This article does not contain any studies with human participants or animals performed by any of the authors.